02/19/2025
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:36 PM | ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:33 PM | Iterum Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/07/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/23/2025
5:30 PM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
6:04 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:54 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ITRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024
10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:00 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:20 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/30/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
7:59 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
8:01 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/23/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/11/2024
3:50 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/09/2024
5:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
08/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:00 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Fishman Corey N. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:28 PM | Iterum Therapeutics (Filer)
| Form POS AM | |
08/06/2024
4:25 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/22/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
07/19/2024
4:05 PM | Iterum Therapeutics (Filer)
| Form 424B3 | |
07/17/2024
3:21 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/26/2024
4:24 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
4:27 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
“Amazon Coin” set to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2025 |
06/21/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:11 PM | Iterum Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/31/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:00 AM | Iterum Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
7:16 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
